SEC Form 13F
| Report period | 2025-12-31 |
|---|---|
| Publicly available | 2026-02-18 |
| Reported value | $72,368,189 |
| Positions | 3 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| BEAM THERAPEUTICS INC | BEAM | COM | $35,119,410 | 1,266,934 |
| LYELL IMMUNOPHARMA INC | LYEL | COM NEW | $31,029,810 | 1,008,116 |
| PRIME MEDICINE INC | PRME | COM | $6,218,969 | 1,792,210 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.